For example, studies suggest that tumor-promoting Th2 cells exhibit high levels of IL-10 and TGF-β, whereas Th2 cells with elevated expression of IL-3, IL-5, and IL-13 demonstrate anti-tumor immunity (31, 32). This evidence concerns the gene IL3 and neoplasm.